Skip to main content

Table 6 Costs

From: Impact of an enhanced recovery pathway on length of stay and complications in elective radical cystectomy: a before and after cohort study

 

Historical controls (N = 100)

ERAS patients (N = 100)

p value

Labs

2378.84 (1183.74)

2123.44 (1094.39)

0.0461

Radiology

1742.60 (2636.01)

723.96 (971.44)

< 0.0011

Outpatient clinic

51.50 (106.67)

302.08 (251.84)

< 0.0011

PT/OT/speech services

833.29 (958.07)

498.54 (454.28)

< 0.0011

Pharmacy

5163.23 (5132.04)

3519.94 (2265.40)

0.0441

Surgery services

10,443.95 (4281.63)

10,954.26 (5739.40)

0.7001

Organ acquisition

2.62 (26.18)

94.34 (943.37)

1.0001

Blood products

1602.18 (1567.09)

930.27 (1056.96)

< 0.0011

Cardiology services

256.10 (729.06)

114.49 (279.73)

0.0051

Respiratory care

1410.74 (4826.77)

168.77 (387.66)

< 0.0011

Intensive care nursing services

6785.91 (9252.27)

3396.64 (5660.55)

< 0.0011

Intermediate care nursing services

12,379.30 (9111.22)

8836.85 (5924.26)

0.0011

Medical/surgical supplies

708.80 (1548.63)

346.38 (641.13)

< 0.0011

ER transport

18.41 (130.93)

8.22 (82.20)

0.5661

Other diagnostic and therapeutics

212.80 (704.33)

263.99 (1443.88)

0.0621

Other

0.00 (0.00)

19.69 (196.93)

0.3221

Total costs

43,990.26 (28,496.09)

32,301.85 (18,756.60)

< 0.0011

  1. Continuous variables reported as mean (sd); all cost data reported in dollars
  2. 1Wilcoxon